C4X Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Valerio Therapeutics SA

Watchlist Manager

Watchlist

Price: 0.776 EUR -2.63%

Market Cap: €239.6m

V	Valerio Therapeutics SA XMUN:C4X	FR
	Look Holdings Inc F:LOO	JP
W	World Copper Ltd F:7LY	CA
	Performance Shipping Inc F:DS2	GR
	Bank Permata Tbk PT F:BABB	ID
F	First Pacific Co Ltd XMUN:FPC	HK
	Keihan Holdings Co Ltd F:59X	JP
K	Kingkey Intelligence Culture Holdings Ltd F:REC	HK
	DigitalBridge Group Inc F:6CL	US

Profitability Summary

Valerio Therapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

66% > 67%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-724%

Operating Margin is Increasing

-1.372% > -21%

Negative Net Margin

-190%

Negative 3Y Average Net Margin

-883%

Net Margin is Increasing

-1.395% > -190%

Exceptional Free Cash Flow Margin

20%

Negative 3Y Average Free Cash Flow Margin

-540%

Free Cash Flow Margin is Increasing

-1.224% > 20%

Exceptional ROE

143%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-64%

ROIC is Increasing

-83% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.